There are currently 12 ongoing clinical trials involving Anosmia
Of the 12 trials,5 trials are in Phase II
Furthermore, 3 trials are in Phase IV
The global pharmaceutical industry is steadily developing new drugs for Anosmia, a Central Nervous System indication. The highest number of ongoing clinical trials involving Anosmia is in North America. The Middle East and Africa and Asia-Pacific are among some of the other prominent regions involved in Anosmia-related drug trials.
Icahn School of Medicine at Mount Sinai: The leading ongoing Anosmia-related clinical trials sponsor
Icahn School of Medicine at Mount Sinai, the United States of America-based private institute, is the top sponsor for Anosmia-related ongoing clinical trials.
Beijing Children's Hospital, Deraya University, ClinAmygate, University of Pittsburgh, and Bagheiat-Allah University of Medical Sciences are a few other notable sponsors involving Anosmia.
A clinical trial sponsor can be a Company, Government, Individual, or Institution.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
Germany
France
Switzerland
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward